December 14, 2021
Jupiter Wellness, Inc. Investigation
We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jupiter Wellness, Inc. (“Jupiter” or the “Company”) (NASDAQ: JUPW), in connection with the proposed merger of the Company with Next Frontier Pharmaceuticals, Inc. (“Next Frontier Pharmaceuticals”). Under the terms of the merger agreement, Next Frontier Pharmaceuticals’ stockholders will be entitled to receive convertible stock of Jupiter Wellness that is convertible into 65,000,000, shares of Jupiter Wellness common stock at the closing of the transaction.
Join Case →